Evidence map›Paper›PMID 38085497›Full record

ArticleSleep & breathing = Schlaf & Atmung2024

Comparing efficacy of the mandibular advancement device after drug-induced sleep endoscopy and continuous positive airway pressure in patients with obstructive sleep apnea.

Evgenia Sp Gogou, Vasileios Psarras, Nikolaos Nikitas Giannakopoulos, Aliki Minaritzoglou, Ioannis A Tsolakis, Vasileios Margaritis, Michail Ger Tzakis

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Sleep & breathing = Schlaf & Atmung, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Evgenia Sp GogouSchool of Dentistry, Orofacial Pain Clinic, National and Kapodistrian University of Athens, 11527, Athens, Greece. eugeniagogou@gmail.com.ORCID 0000-0003-2599-4956
Vasileios PsarrasSchool of Dentistry, Orofacial Pain Clinic, National and Kapodistrian University of Athens, 11527, Athens, Greece.
Nikolaos Nikitas GiannakopoulosDepartment of Prosthodontics, School of Dentistry, National and Kapodistrian University of Athens, 11527, Athens, Greece.
Aliki MinaritzoglouCenter of Sleep Disorders, Department of Critical Care and Pulmonary Services, Medical School of National and Kapodistrian University of Athens, Evaggelismos Hospital, Athens, Greece.
Ioannis A TsolakisDepartment of Orthodontics, School of Dentistry, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.
Vasileios MargaritisResearch Center, Swiss School of Management, Bellinzona, Switzerland.
Michail Ger TzakisSchool of Dentistry, Orofacial Pain Clinic, National and Kapodistrian University of Athens, 11527, Athens, Greece.
National and Kapodistrian University of Athens · GRAristotle University of Thessaloniki · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study was to compare objective and self-reported outcomes of two treatments for managing mild, moderate, and severe obstructive sleep apnea (OSA) in adults: a mandibular advancement device (MAD) and continuous positive airway pressure (CPAP).

methodsPatients diagnosed with OSA by means of polysomnography (PSG) included one group treated with a custom-made, two-piece, adjustable MAD and a second group treated with CPAP for 8 weeks. Before the initiation of the treatment, all patients assigned to MAD underwent drug-induced sleep endoscopy (DISE), and all CPAP group patients underwent manual titration of CPAP after PSG. Objective (PSG) and self-reported (Epworth Sleepiness Scale [ESS] and Short Form Health Survey [SF-36]) data were used to assess outcomes. Collected data included apnea-hypopnea index (AHI), mean capillary oxygen saturation (SpO

resultsA total of 59 patients included 30 treated with MAD and 29 treated with CPAP. Between baseline and the 8-week follow-up, the mean AHI score decreased significantly from 35.1 to 6.8 episodes/h (p < 0.001) in patients treated with MAD and from 35.2 to 3.0 episodes/h (p < 0.001) in patients treated with CPAP. The mean AHI score at the 8-week follow-up was significantly lower in CPAP group than in MAD group (p = 0.003). The two groups did not differ significantly at follow-up regarding SpO

conclusionIn the short term, patients on CPAP attained better PSG outcomes in terms of AHI reduction. Both MAD after DISE evaluation and CPAP resulted in similar improvements in clinical symptoms and health-related quality of life, even in patients with severe OSA.

Indexed as

Continuous Positive Airway PressureEndoscopyMandibular AdvancementPolysomnographySleep Apnea, ObstructiveAdultAgedFemaleHumansMaleMiddle AgedQuality of LifeTreatment OutcomeContinuous positive airway pressureDrug-induced sleep endoscopyMandibular advancement deviceObstructive sleep apneaPolysomnography

Identifiers

PMID38085497
OpenAlexW4389612482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.